[{"Assets_0_Q3_USD":190761000.0,"CommonStockSharesOutstanding_0_Q3_shares":50428507.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":31745000.0,"NetIncomeLoss_1_Q3_USD":-10890000.0,"NetIncomeLoss_3_Q3_USD":-27181000.0,"StockholdersEquity_0_Q3_USD":21472000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":8975000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":33543000.0,"Ticker":"CCXI","CIK":"1340652","name":"CHEMOCENTRYX, INC.","OfficialName":"ChemoCentryx Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1508212562.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]